Zuck, M., Grogan, B., Sakai, C., Gutierrez, L., Repetny, K., Fanale, M. A., Lu, H., George, P., Heiser, R., O'Connor, B. P. (2026). Treatment with brentuximab vedotin in vitro and CAR T-cell function and viability: Implications for combination or sequential therapeutic approaches for lymphoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e15014